GlassScriptPhysician profile
Mary E Kaiser
NPI 1144242371
$12,093.62
in general payments reported to CMS, 2019-2025
14 companies · $733 in 2025
The $733 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,623 · 2022: $3,038 · 2023: $1,593 · 2024: $1,108 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,197 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200 · Education: $20.00 · Travel and Lodging: $17.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,196.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
| Education | $20.00 |
| Travel and Lodging | $17.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $10,857.30 | 2021-2025 | Puraply Antimicrobial, Affinity, Puraply |
| Smith+Nephew, INC. | $637.45 | 2023-2025 | Collagenase Santyl, Oasis, Grafix Pl |
| Tactile Systems Technology INC | $219.26 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medela LLC | $74.80 | 2022 | |
| Solventum Corporation | $66.24 | 2024-2025 | Activ.A.C. |
| Mimedx Group, INC. | $47.04 | 2024-2025 | |
| Integra Lifesciences Corporation | $35.42 | 2023-2025 | Tcc-Ez |
| Bioventus LLC | $33.69 | 2022-2023 | |
| Kerecis Limited | $30.94 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hydrofera LLC | $25.83 | 2023 | Hydrofera Blue |
| Abbvie INC. | $22.09 | 2025 | |
| Cashflow Solutions, LLC | $15.93 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Kci USA, INC. | $14.07 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.56 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.